SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ — Aethlon Medical,
Inc. (OTC Bulletin Board:
AEMD), the pioneer in developing therapeutic filtration devices
to address infectious disease and cancer, announced today that it
has named Rod Kenley to be President of Aethlon Medical.
Aethlon Chairman and CEO, Jim Joyce, previously also held the
title of President. Mr. Kenley recently joined Aethlon’s
Board of Directors and will retain his Board seat as an inside
director.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
(Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
“We are extremely pleased to have Rod become a full-time member
of our team,” stated Jim Joyce. “As referenced when he joined
our board, Rod has been instrumental in commercializing some of the
most important advances in the dialysis industry. He is among the
best in industry talent, whose full focus towards our endeavors
will immediately impact our business and improve our efficiency in
advancing established and future opportunities.”
Mr. Kenley has 33 years of experience in healthcare, most of
which have been spent in the extracorporeal blood purification
arena. Mr. Kenley held several positions at Baxter Healthcare
(Travenol) from 1977 through 1990 including International Marketing
Manager, Business Unit Manager for Peritoneal and Hemodialysis
products, Manager of New Business Development, Director of
Worldwide Product Planning, Director of Advanced Product
Development, and VP of Electronic Drug Infusion. During this
tenure, he conceived of and managed the launch of several new
products that have been highly commercially successful including
the HomeChoice peritoneal dialysis cyc
‘/>”/>
